top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
iScreen Shoter - 20261028172009135.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
Frame 1000008569.png
Frame 1000008568.png
4acc1a9d-ced8-4f58-a79e-cd2ac6fe752e.png
Frame 1410148109.png
Frame 100000825.png
Frame i1000008267.png
Frame 1410148108.png
Frame 10000082699.png
Fra 1000008266.png
Frame 1000i008268.png
Frame 1410148110.png
Frame 100070.png
Frame 1410148111.png
valve.png

One Scan. All These Reports.

From Calcium Scoring and Lung Screening to Comprehensive Health Insights - with AI.

Should We Screen Asymptomatic Patients with Coronary CT?

Jul 19
1 min read

Coronary CT has become one of the most powerful imaging technologies for cardiovascular risk assessment. However, an important clinical question remains: Should Coronary CT Angiography (CCTA) be used routinely to screen asymptomatic individuals, or does Coronary Artery Calcium (CAC) scanning already provide sufficient information for preventive care?




This presentation reviews the current evidence comparing CAC scoring and CCTA in primary prevention, examining their predictive performance, clinical value, cost-effectiveness, and impact on patient management. While CCTA provides detailed visualization of coronary plaque morphology, non-calcified plaque, stenosis, and other high-risk features, the available evidence suggests that its incremental benefit over CAC alone remains relatively modest for broad population screening, particularly among individuals with a CAC score of zero.

Drawing on data from major studies—including SCAPIS, CONFIRM, SCOT-HEART, and other contemporary investigations—the presentation argues that CAC remains the most practical, scalable, and cost-effective first-line screening tool for asymptomatic adults. Rather than replacing CAC, CCTA may provide its greatest value in carefully selected higher-risk individuals, especially those with elevated CAC scores where plaque characterization can meaningfully influence treatment decisions and preventive strategies.

The presentation concludes by proposing a CAC-first screening strategy, followed by selective CCTA only when additional plaque characterization is likely to change clinical management. This approach aims to maximize diagnostic value while minimizing unnecessary cost, contrast exposure, radiation, and downstream testing, ultimately supporting a more evidence-based and efficient model of cardiovascular prevention.

Download the complete presentation below to explore the latest evidence comparing CAC and CCTA, review the major clinical trials, and understand the evolving role of coronary CT in preventive cardiology.



Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png
iScreen Shoter - 20261104171348520.jpg

©2026 HeartLung Corporation. All Rights Reserved. U.S. Patent Nos. 12,620,494; 12,599,350; 11,610,686. Licensed U.S. Patent Nos. 9,119,590 and 10,695,022. U.S. Patent Applications Pending: 19/390,544; 19/403,750; 19/643,672; 19/728,738; 19/741,766; 18/652,123; 18/771,542; 19/390,629; 19/417,345; 19/467,802; 19/565,385; 19/682,416; 19/690,066. International PCT Applications: PCT/US2025/058510; PCT/US2025/061047; PCT/US2025/058505; PCT/US2026/013566; PCT/US2026/024304. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoLiver, AutoChamber, AutoLung and other product names and trademarks displayed on this website are protected by applicable intellectual property laws. All rights reserved.

bottom of page